{"transactions":[{"id":4638882,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-09T23:07:49.000Z","date":"2026-10-08","kind":"exercise","planned":true,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026."}],"balance_after":0,"derivative":{"exercise_price":32.35,"expiration_date":"2026-12-07","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001628280-26-065566","document":"wk-form4_1791587267.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1545439/000162828026065566/wk-form4_1791587267.xml","form_type":"4"}},{"id":4638881,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-10-09T23:07:49.000Z","date":"2026-10-08","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":36.32,"value":217920.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026."}],"balance_after":62284.242,"source":{"system":"sec-edgar","filing":"0001628280-26-065566","document":"wk-form4_1791587267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1545439/000162828026065566/wk-form4_1791587267.xml","form_type":"4"}},{"id":4638880,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-10-09T23:07:49.000Z","date":"2026-10-08","kind":"exercise","planned":true,"acquired":true,"shares":6000,"price":32.35,"value":194100.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026."}],"balance_after":68284.242,"source":{"system":"sec-edgar","filing":"0001628280-26-065566","document":"wk-form4_1791587267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1545439/000162828026065566/wk-form4_1791587267.xml","form_type":"4"}},{"id":683749,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-18T21:21:16.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":3040,"price":23.23,"value":70619.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on August 12, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 511.471 shares of common stock acquired under the issuer's employee stock purchase plan in June 2026."}],"balance_after":216383.646,"source":{"system":"sec-edgar","filing":"0001628280-26-057759","document":"wk-form4_1787088074.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000162828026057759/wk-form4_1787088074.xml","form_type":"4"}},{"id":739330,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-06-13T01:07:46.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":6115,"price":23.5,"value":143702.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026."}],"balance_after":62284.242,"source":{"system":"sec-edgar","filing":"0001628280-26-043009","document":"wk-form4_1781312864.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026043009/wk-form4_1781312864.xml","form_type":"4"}},{"id":739329,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38597,"kind":"person","name":"CHRISTIE CHRISTOPHER","position":1,"cik":"0001787688","reported_name":"CHRISTIE CHRISTOPHER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-13T01:07:38.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":10891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":10891,"derivative":{"exercise_price":23.42,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":10891},"source":{"system":"sec-edgar","filing":"0001628280-26-043008","document":"wk-form4_1781312856.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026043008/wk-form4_1781312856.xml","form_type":"4"}},{"id":739328,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38597,"kind":"person","name":"CHRISTIE CHRISTOPHER","position":1,"cik":"0001787688","reported_name":"CHRISTIE CHRISTOPHER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-13T01:07:38.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":6405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":23059,"source":{"system":"sec-edgar","filing":"0001628280-26-043008","document":"wk-form4_1781312856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026043008/wk-form4_1781312856.xml","form_type":"4"}},{"id":739468,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":26600,"kind":"person","name":"WIGGANS THOMAS G","position":1,"cik":"0001208907","reported_name":"WIGGANS THOMAS G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-13T01:07:30.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":32675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal monthly installments over the subsequent two years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":32675,"derivative":{"exercise_price":23.42,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":32675},"source":{"system":"sec-edgar","filing":"0001628280-26-043007","document":"wk-form4_1781312848.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1208907/000162828026043007/wk-form4_1781312848.xml","form_type":"4"}},{"id":739327,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38596,"kind":"person","name":"Young Alethia","position":1,"cik":"0001918147","reported_name":"Young Alethia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-13T01:07:23.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":10891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":10891,"derivative":{"exercise_price":23.42,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":10891},"source":{"system":"sec-edgar","filing":"0001628280-26-043006","document":"wk-form4_1781312840.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026043006/wk-form4_1781312840.xml","form_type":"4"}},{"id":739326,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38596,"kind":"person","name":"Young Alethia","position":1,"cik":"0001918147","reported_name":"Young Alethia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-13T01:07:23.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":6405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":17798,"source":{"system":"sec-edgar","filing":"0001628280-26-043006","document":"wk-form4_1781312840.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026043006/wk-form4_1781312840.xml","form_type":"4"}},{"id":739325,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-13T01:07:15.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":10891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":10891,"derivative":{"exercise_price":23.42,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":10891},"source":{"system":"sec-edgar","filing":"0001628280-26-043005","document":"wk-form4_1781312832.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026043005/wk-form4_1781312832.xml","form_type":"4"}},{"id":739324,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-13T01:07:15.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":6405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":19798,"source":{"system":"sec-edgar","filing":"0001628280-26-043005","document":"wk-form4_1781312832.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026043005/wk-form4_1781312832.xml","form_type":"4"}},{"id":739323,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38595,"kind":"person","name":"BIGAL MARCELO","position":1,"cik":"0001996637","reported_name":"BIGAL MARCELO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-13T01:07:07.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":10891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":10891,"derivative":{"exercise_price":23.42,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":10891},"source":{"system":"sec-edgar","filing":"0001628280-26-043004","document":"wk-form4_1781312824.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026043004/wk-form4_1781312824.xml","form_type":"4"}},{"id":739322,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38595,"kind":"person","name":"BIGAL MARCELO","position":1,"cik":"0001996637","reported_name":"BIGAL MARCELO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-13T01:07:07.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":6405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":17798,"source":{"system":"sec-edgar","filing":"0001628280-26-043004","document":"wk-form4_1781312824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026043004/wk-form4_1781312824.xml","form_type":"4"}},{"id":739368,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-13T01:06:51.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":10891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":10891,"derivative":{"exercise_price":23.42,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":10891},"source":{"system":"sec-edgar","filing":"0001628280-26-043002","document":"wk-form4_1781312808.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000162828026043002/wk-form4_1781312808.xml","form_type":"4"}},{"id":739367,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-13T01:06:51.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":6405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":30120,"source":{"system":"sec-edgar","filing":"0001628280-26-043002","document":"wk-form4_1781312808.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000162828026043002/wk-form4_1781312808.xml","form_type":"4"}},{"id":740014,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":15098,"kind":"person","name":"Hirawat Samit","position":1,"cik":"0001781290","reported_name":"Hirawat Samit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T21:07:54.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":10891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":10891,"derivative":{"exercise_price":23.42,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":10891},"source":{"system":"sec-edgar","filing":"0001628280-26-043010","document":"wk-form4_1781312871.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1781290/000162828026043010/wk-form4_1781312871.xml","form_type":"4"}},{"id":740013,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":15098,"kind":"person","name":"Hirawat Samit","position":1,"cik":"0001781290","reported_name":"Hirawat Samit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:07:54.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":6405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":6405,"source":{"system":"sec-edgar","filing":"0001628280-26-043010","document":"wk-form4_1781312871.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781290/000162828026043010/wk-form4_1781312871.xml","form_type":"4"}},{"id":739873,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T21:06:59.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":10891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":10891,"derivative":{"exercise_price":23.42,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":10891},"source":{"system":"sec-edgar","filing":"0001628280-26-043003","document":"wk-form4_1781312816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000162828026043003/wk-form4_1781312816.xml","form_type":"4"}},{"id":739872,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:06:59.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":6405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":26541,"source":{"system":"sec-edgar","filing":"0001628280-26-043003","document":"wk-form4_1781312816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000162828026043003/wk-form4_1781312816.xml","form_type":"4"}},{"id":747589,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-06-05T21:57:16.000Z","date":"2026-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":3187,"price":22.32,"value":71133.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."}],"balance_after":68399.242,"source":{"system":"sec-edgar","filing":"0001628280-26-041332","document":"wk-form4_1780696632.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026041332/wk-form4_1780696632.xml","form_type":"4"}},{"id":748210,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-05T21:57:08.000Z","date":"2026-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":4728,"price":22.32,"value":105528.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."}],"balance_after":218912.175,"source":{"system":"sec-edgar","filing":"0001628280-26-041331","document":"wk-form4_1780696625.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000162828026041331/wk-form4_1780696625.xml","form_type":"4"}},{"id":747756,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":40880,"kind":"person","name":"WILLIAMS KRISTEN","position":1,"cik":"0001296965","reported_name":"WILLIAMS KRISTEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Common Stock","published_at":"2026-06-05T21:57:00.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":10259,"price":22.27,"value":228467.93,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on September 10, 2025."}],"balance_after":167062,"source":{"system":"sec-edgar","filing":"0001628280-26-041330","document":"wk-form4_1780696617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1296965/000162828026041330/wk-form4_1780696617.xml","form_type":"4"}},{"id":747755,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":40880,"kind":"person","name":"WILLIAMS KRISTEN","position":1,"cik":"0001296965","reported_name":"WILLIAMS KRISTEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Common Stock","published_at":"2026-06-05T21:57:00.000Z","date":"2026-06-03","kind":"tax_withholding","planned":true,"acquired":false,"shares":8528,"price":22.32,"value":190344.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."}],"balance_after":177321,"source":{"system":"sec-edgar","filing":"0001628280-26-041330","document":"wk-form4_1780696617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296965/000162828026041330/wk-form4_1780696617.xml","form_type":"4"}},{"id":800991,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-25T00:41:26.000Z","date":"2026-04-23","kind":"exercise","planned":true,"acquired":false,"shares":12941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."}],"balance_after":150000,"derivative":{"exercise_price":16.45,"expiration_date":"2034-11-04","underlying":"Common Stock","underlying_shares":12941},"source":{"system":"sec-edgar","filing":"0001628280-26-027287","document":"wk-form4_1777077683.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026027287/wk-form4_1777077683.xml","form_type":"4"}},{"id":800990,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-25T00:41:26.000Z","date":"2026-04-23","kind":"sale","planned":true,"acquired":false,"shares":12941,"price":25.16,"value":325595.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.41, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":105341,"source":{"system":"sec-edgar","filing":"0001628280-26-027287","document":"wk-form4_1777077683.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026027287/wk-form4_1777077683.xml","form_type":"4"}},{"id":800989,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-25T00:41:26.000Z","date":"2026-04-23","kind":"exercise","planned":true,"acquired":true,"shares":12941,"price":16.45,"value":212879.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."}],"balance_after":118282,"source":{"system":"sec-edgar","filing":"0001628280-26-027287","document":"wk-form4_1777077683.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026027287/wk-form4_1777077683.xml","form_type":"4"}},{"id":802916,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-23T00:03:15.000Z","date":"2026-04-22","kind":"exercise","planned":true,"acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."}],"balance_after":162941,"derivative":{"exercise_price":16.45,"expiration_date":"2034-11-04","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001628280-26-026669","document":"wk-form4_1776902593.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026026669/wk-form4_1776902593.xml","form_type":"4"}},{"id":802915,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-23T00:03:15.000Z","date":"2026-04-21","kind":"exercise","planned":true,"acquired":false,"shares":2845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."}],"balance_after":164441,"derivative":{"exercise_price":16.45,"expiration_date":"2034-11-04","underlying":"Common Stock","underlying_shares":2845},"source":{"system":"sec-edgar","filing":"0001628280-26-026669","document":"wk-form4_1776902593.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026026669/wk-form4_1776902593.xml","form_type":"4"}},{"id":802914,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-23T00:03:15.000Z","date":"2026-04-20","kind":"exercise","planned":true,"acquired":false,"shares":7714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."}],"balance_after":167286,"derivative":{"exercise_price":16.45,"expiration_date":"2034-11-04","underlying":"Common Stock","underlying_shares":7714},"source":{"system":"sec-edgar","filing":"0001628280-26-026669","document":"wk-form4_1776902593.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026026669/wk-form4_1776902593.xml","form_type":"4"}},{"id":802913,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-23T00:03:15.000Z","date":"2026-04-22","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":25.01,"value":37515.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.04, inclusive."}],"balance_after":105341,"source":{"system":"sec-edgar","filing":"0001628280-26-026669","document":"wk-form4_1776902593.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026026669/wk-form4_1776902593.xml","form_type":"4"}},{"id":802912,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-23T00:03:15.000Z","date":"2026-04-22","kind":"exercise","planned":true,"acquired":true,"shares":1500,"price":16.45,"value":24675.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."}],"balance_after":106841,"source":{"system":"sec-edgar","filing":"0001628280-26-026669","document":"wk-form4_1776902593.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026026669/wk-form4_1776902593.xml","form_type":"4"}},{"id":802911,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-23T00:03:15.000Z","date":"2026-04-21","kind":"sale","planned":true,"acquired":false,"shares":2845,"price":25.01,"value":71153.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.04, inclusive."}],"balance_after":105341,"source":{"system":"sec-edgar","filing":"0001628280-26-026669","document":"wk-form4_1776902593.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026026669/wk-form4_1776902593.xml","form_type":"4"}},{"id":802910,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-23T00:03:15.000Z","date":"2026-04-21","kind":"exercise","planned":true,"acquired":true,"shares":2845,"price":16.45,"value":46800.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."}],"balance_after":108186,"source":{"system":"sec-edgar","filing":"0001628280-26-026669","document":"wk-form4_1776902593.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026026669/wk-form4_1776902593.xml","form_type":"4"}},{"id":802909,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-23T00:03:15.000Z","date":"2026-04-20","kind":"sale","planned":true,"acquired":false,"shares":7714,"price":25.14,"value":193929.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.31, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2 and 3."}],"balance_after":105341,"source":{"system":"sec-edgar","filing":"0001628280-26-026669","document":"wk-form4_1776902593.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026026669/wk-form4_1776902593.xml","form_type":"4"}},{"id":802908,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-23T00:03:15.000Z","date":"2026-04-20","kind":"exercise","planned":true,"acquired":true,"shares":7714,"price":16.45,"value":126895.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."}],"balance_after":113055,"source":{"system":"sec-edgar","filing":"0001628280-26-026669","document":"wk-form4_1776902593.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026026669/wk-form4_1776902593.xml","form_type":"4"}},{"id":833198,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":57065,"kind":"person","name":"Kronenfeld Mark A.","position":1,"cik":"0001578074","reported_name":"Kronenfeld Mark A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-19T21:43:16.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":6163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":31065,"source":{"system":"sec-edgar","filing":"0001628280-26-019892","document":"wk-form4a_1773956593.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026019892/wk-form4a_1773956593.xml","form_type":"4/A","original_submission_date":"2025-06-13"}},{"id":833639,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-19T21:43:08.000Z","date":"2026-03-17","kind":"sale","planned":true,"acquired":false,"shares":3261,"price":22.82,"value":74416.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on August 12, 2025."}],"balance_after":223640.175,"source":{"system":"sec-edgar","filing":"0001628280-26-019891","document":"wk-form4_1773956586.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000162828026019891/wk-form4_1773956586.xml","form_type":"4"}},{"id":833530,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-19T17:43:00.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":500,"price":21.81,"value":10905.0,"ownership":{"direct":true},"balance_after":20136,"source":{"system":"sec-edgar","filing":"0001628280-26-019890","document":"wk-form4_1773956578.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000162828026019890/wk-form4_1773956578.xml","form_type":"4"}},{"id":905279,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-13T21:02:23.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":49091,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on February 15, 2027, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":105341,"source":{"system":"sec-edgar","filing":"0001628280-26-008080","document":"wk-form4_1771016540.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026008080/wk-form4_1771016540.xml","form_type":"4"}},{"id":904935,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":40880,"kind":"person","name":"WILLIAMS KRISTEN","position":1,"cik":"0001296965","reported_name":"WILLIAMS KRISTEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Common Stock","published_at":"2026-02-13T21:02:16.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":54546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on February 15, 2027, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":185849,"source":{"system":"sec-edgar","filing":"0001628280-26-008078","document":"wk-form4_1771016534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296965/000162828026008078/wk-form4_1771016534.xml","form_type":"4"}},{"id":904819,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-13T21:02:10.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":51714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on February 15, 2027, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":100934.268,"source":{"system":"sec-edgar","filing":"0001628280-26-008077","document":"wk-form4_1771016527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026008077/wk-form4_1771016527.xml","form_type":"4"}},{"id":904816,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-02-13T21:02:03.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":19273,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on February 15, 2027, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":71586.242,"source":{"system":"sec-edgar","filing":"0001628280-26-008076","document":"wk-form4_1771016519.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026008076/wk-form4_1771016519.xml","form_type":"4"}},{"id":905381,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-13T21:01:56.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":54546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on February 15, 2027, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":226901.175,"source":{"system":"sec-edgar","filing":"0001628280-26-008075","document":"wk-form4_1771016513.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000162828026008075/wk-form4_1771016513.xml","form_type":"4"}},{"id":904815,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":44453,"kind":"person","name":"Lee Frank D.","position":1,"cik":"0001814686","reported_name":"Lee Frank D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-13T21:01:50.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":261818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on February 15, 2027, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":660830.841,"source":{"system":"sec-edgar","filing":"0001628280-26-008074","document":"wk-form4_1771016507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026008074/wk-form4_1771016507.xml","form_type":"4"}},{"id":921281,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-02-03T23:24:09.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":20.81,"value":83240.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.35 to $21.28, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 3."}],"balance_after":52313.242,"source":{"system":"sec-edgar","filing":"0001628280-26-005158","document":"wk-form4_1770161045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026005158/wk-form4_1770161045.xml","form_type":"4"}},{"id":921280,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-02-03T23:24:09.000Z","date":"2026-01-30","kind":"tax_withholding","planned":true,"acquired":false,"shares":2751,"price":20.54,"value":56505.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."}],"balance_after":56313.242,"source":{"system":"sec-edgar","filing":"0001628280-26-005158","document":"wk-form4_1770161045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026005158/wk-form4_1770161045.xml","form_type":"4"}},{"id":921527,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":40880,"kind":"person","name":"WILLIAMS KRISTEN","position":1,"cik":"0001296965","reported_name":"WILLIAMS KRISTEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Common Stock","published_at":"2026-02-03T23:24:01.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":13137,"price":20.53,"value":269702.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":131303,"source":{"system":"sec-edgar","filing":"0001628280-26-005157","document":"wk-form4_1770161039.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1296965/000162828026005157/wk-form4_1770161039.xml","form_type":"4"}},{"id":921526,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":40880,"kind":"person","name":"WILLIAMS KRISTEN","position":1,"cik":"0001296965","reported_name":"WILLIAMS KRISTEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Common Stock","published_at":"2026-02-03T23:24:01.000Z","date":"2026-01-30","kind":"tax_withholding","planned":true,"acquired":false,"shares":17134,"price":20.54,"value":351932.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."}],"balance_after":144440,"source":{"system":"sec-edgar","filing":"0001628280-26-005157","document":"wk-form4_1770161039.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296965/000162828026005157/wk-form4_1770161039.xml","form_type":"4"}},{"id":922179,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-03T23:23:53.000Z","date":"2026-01-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":6168,"price":20.54,"value":126690.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."}],"balance_after":172355.175,"source":{"system":"sec-edgar","filing":"0001628280-26-005155","document":"wk-form4_1770161031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000162828026005155/wk-form4_1770161031.xml","form_type":"4"}},{"id":921279,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-03T23:23:46.000Z","date":"2026-01-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":5182,"price":20.54,"value":106438.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."}],"balance_after":49220.268,"source":{"system":"sec-edgar","filing":"0001628280-26-005154","document":"wk-form4_1770161023.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026005154/wk-form4_1770161023.xml","form_type":"4"}},{"id":921278,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":44453,"kind":"person","name":"Lee Frank D.","position":1,"cik":"0001814686","reported_name":"Lee Frank D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-03T23:23:38.000Z","date":"2026-01-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":41488,"price":20.54,"value":852163.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."}],"balance_after":399012.841,"source":{"system":"sec-edgar","filing":"0001628280-26-005153","document":"wk-form4_1770161015.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026005153/wk-form4_1770161015.xml","form_type":"4"}},{"id":927927,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":15098,"kind":"person","name":"Hirawat Samit","position":1,"cik":"0001781290","reported_name":"Hirawat Samit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-29T16:57:18.000Z","date":"2026-01-27","kind":"grant","planned":false,"acquired":true,"shares":39291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal monthly\ninstallments over the subsequent two years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":39291,"derivative":{"exercise_price":19.85,"expiration_date":"2036-01-27","underlying":"Common Stock","underlying_shares":39291},"source":{"system":"sec-edgar","filing":"0001628280-26-004188","document":"wk-form4_1769723829.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781290/000162828026004188/wk-form4_1769723829.xml","form_type":"4"}},{"id":947116,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-06T22:30:54.000Z","date":"2026-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":381,"price":24.46,"value":9319.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 537.166 shares of common stock acquired under the issuer's employee stock purchase plan in December 2025."}],"balance_after":178523.175,"source":{"system":"sec-edgar","filing":"0001628280-26-000968","document":"wk-form4_1767738651.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000162828026000968/wk-form4_1767738651.xml","form_type":"4"}},{"id":945856,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-01-06T22:30:45.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":1416,"price":24.24,"value":34323.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":59064.242,"source":{"system":"sec-edgar","filing":"0001628280-26-000967","document":"wk-form4_1767738641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026000967/wk-form4_1767738641.xml","form_type":"4"}},{"id":945855,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-01-06T22:30:45.000Z","date":"2026-01-02","kind":"tax_withholding","planned":true,"acquired":false,"shares":159,"price":24.46,"value":3889.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,075.242 shares of common stock acquired under the issuer's employee stock purchase plan in December 2025."}],"balance_after":60480.242,"source":{"system":"sec-edgar","filing":"0001628280-26-000967","document":"wk-form4_1767738641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026000967/wk-form4_1767738641.xml","form_type":"4"}},{"id":945853,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":44453,"kind":"person","name":"Lee Frank D.","position":1,"cik":"0001814686","reported_name":"Lee Frank D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-06T22:30:37.000Z","date":"2026-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":9272,"price":24.46,"value":226793.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,363.841 shares of common stock acquired under the issuer's employee stock purchase plan in June 2025."}],"balance_after":440500.841,"source":{"system":"sec-edgar","filing":"0001628280-26-000966","document":"wk-form4_1767738633.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026000966/wk-form4_1767738633.xml","form_type":"4"}},{"id":945854,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-06T22:30:28.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":402.268,"price":10.763,"value":4329.610484,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock acquired under the issuer's employee stock purchase plan in December 2025."}],"balance_after":54402.268,"source":{"system":"sec-edgar","filing":"0001628280-26-000964","document":"wk-form4_1767738624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026000964/wk-form4_1767738624.xml","form_type":"4"}},{"id":972697,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-12T02:47:00.000Z","date":"2025-12-10","kind":"exercise","planned":true,"acquired":false,"shares":9104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":175000,"derivative":{"exercise_price":16.45,"expiration_date":"2034-11-04","underlying":"Common Stock","underlying_shares":9104},"source":{"system":"sec-edgar","filing":"0001628280-25-056645","document":"wk-form4_1765507617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828025056645/wk-form4_1765507617.xml","form_type":"4"}},{"id":972696,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-12T02:47:00.000Z","date":"2025-12-09","kind":"exercise","planned":true,"acquired":false,"shares":15896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":184104,"derivative":{"exercise_price":16.45,"expiration_date":"2034-11-04","underlying":"Common Stock","underlying_shares":15896},"source":{"system":"sec-edgar","filing":"0001628280-25-056645","document":"wk-form4_1765507617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828025056645/wk-form4_1765507617.xml","form_type":"4"}},{"id":972695,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-12T02:47:00.000Z","date":"2025-12-10","kind":"sale","planned":true,"acquired":false,"shares":9104,"price":25.14,"value":228874.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.30, inclusive."}],"balance_after":56250,"source":{"system":"sec-edgar","filing":"0001628280-25-056645","document":"wk-form4_1765507617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828025056645/wk-form4_1765507617.xml","form_type":"4"}},{"id":972694,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-12T02:47:00.000Z","date":"2025-12-10","kind":"exercise","planned":true,"acquired":true,"shares":9104,"price":16.45,"value":149760.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":65354,"source":{"system":"sec-edgar","filing":"0001628280-25-056645","document":"wk-form4_1765507617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828025056645/wk-form4_1765507617.xml","form_type":"4"}},{"id":972693,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-12T02:47:00.000Z","date":"2025-12-09","kind":"sale","planned":true,"acquired":false,"shares":15896,"price":25.03,"value":397876.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.11, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2 and 3."}],"balance_after":56250,"source":{"system":"sec-edgar","filing":"0001628280-25-056645","document":"wk-form4_1765507617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828025056645/wk-form4_1765507617.xml","form_type":"4"}},{"id":972692,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-12T02:47:00.000Z","date":"2025-12-09","kind":"exercise","planned":true,"acquired":true,"shares":15896,"price":16.45,"value":261489.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":72146,"source":{"system":"sec-edgar","filing":"0001628280-25-056645","document":"wk-form4_1765507617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828025056645/wk-form4_1765507617.xml","form_type":"4"}},{"id":994094,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-19T21:32:02.000Z","date":"2025-11-17","kind":"sale","planned":true,"acquired":false,"shares":3960,"price":24.09,"value":95396.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":178367.009,"source":{"system":"sec-edgar","filing":"0001628280-25-053205","document":"wk-form4_1763587920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000162828025053205/wk-form4_1763587920.xml","form_type":"4"}},{"id":1000295,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-13T21:13:23.000Z","date":"2025-11-10","kind":"sale","planned":true,"acquired":false,"shares":12060,"price":22.09,"value":266405.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":56250,"source":{"system":"sec-edgar","filing":"0001628280-25-052038","document":"wk-form4_1763068400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828025052038/wk-form4_1763068400.xml","form_type":"4"}},{"id":1009634,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-03T22:41:34.000Z","date":"2025-10-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":6690,"price":21.38,"value":143032.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the issuer to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":68310,"source":{"system":"sec-edgar","filing":"0001628280-25-048393","document":"wk-form4_1762209691.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828025048393/wk-form4_1762209691.xml","form_type":"4"}},{"id":1045640,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":19566,"kind":"person","name":"Ceesay Abraham","position":1,"cik":"0001722140","reported_name":"Ceesay Abraham","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-08T21:37:14.000Z","date":"2025-09-04","kind":"sale","planned":true,"acquired":false,"shares":2354,"price":27.19,"value":64005.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":9039,"source":{"system":"sec-edgar","filing":"0001396814-25-000109","document":"wk-form4_1757367430.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000109/wk-form4_1757367430.xml","form_type":"4"}},{"id":1069904,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38595,"kind":"person","name":"BIGAL MARCELO","position":1,"cik":"0001996637","reported_name":"BIGAL MARCELO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-11T20:09:49.000Z","date":"2025-08-07","kind":"sale","planned":false,"acquired":false,"shares":4912,"price":23.67,"value":116267.04,"ownership":{"direct":true},"balance_after":11393,"source":{"system":"sec-edgar","filing":"0001396814-25-000107","document":"wk-form4_1754942983.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000107/wk-form4_1754942983.xml","form_type":"4"}},{"id":1076411,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-08-04T20:31:02.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":315,"price":22.07,"value":6952.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 682.498 shares of common stock acquired under the issuer's employee stock purchase plan in June 2025."}],"balance_after":182327.009,"source":{"system":"sec-edgar","filing":"0001396814-25-000095","document":"wk-form4_1754339458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000139681425000095/wk-form4_1754339458.xml","form_type":"4"}},{"id":1111155,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":57065,"kind":"person","name":"Kronenfeld Mark A.","position":1,"cik":"0001578074","reported_name":"Kronenfeld Mark A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:18:36.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":11279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":11279,"derivative":{"exercise_price":24.34,"exercise_date":"2026-06-11","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":11279},"source":{"system":"sec-edgar","filing":"0001396814-25-000087","document":"wk-form4_1749845910.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000087/wk-form4_1749845910.xml","form_type":"4"}},{"id":1111154,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":57065,"kind":"person","name":"Kronenfeld Mark A.","position":1,"cik":"0001578074","reported_name":"Kronenfeld Mark A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T20:18:36.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":9999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":34901,"source":{"system":"sec-edgar","filing":"0001396814-25-000087","document":"wk-form4_1749845910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000087/wk-form4_1749845910.xml","form_type":"4"}},{"id":1111153,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":19566,"kind":"person","name":"Ceesay Abraham","position":1,"cik":"0001722140","reported_name":"Ceesay Abraham","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:18:26.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":11279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":11279,"derivative":{"exercise_price":24.34,"exercise_date":"2026-06-11","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":11279},"source":{"system":"sec-edgar","filing":"0001396814-25-000086","document":"wk-form4_1749845900.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000086/wk-form4_1749845900.xml","form_type":"4"}},{"id":1111152,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":19566,"kind":"person","name":"Ceesay Abraham","position":1,"cik":"0001722140","reported_name":"Ceesay Abraham","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T20:18:26.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":6163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":11393,"source":{"system":"sec-edgar","filing":"0001396814-25-000086","document":"wk-form4_1749845900.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000086/wk-form4_1749845900.xml","form_type":"4"}},{"id":1111151,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38595,"kind":"person","name":"BIGAL MARCELO","position":1,"cik":"0001996637","reported_name":"BIGAL MARCELO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:18:05.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":11279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":11279,"derivative":{"exercise_price":24.34,"exercise_date":"2026-06-11","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":11279},"source":{"system":"sec-edgar","filing":"0001396814-25-000084","document":"wk-form4_1749845879.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000084/wk-form4_1749845879.xml","form_type":"4"}},{"id":1111150,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38595,"kind":"person","name":"BIGAL MARCELO","position":1,"cik":"0001996637","reported_name":"BIGAL MARCELO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T20:18:05.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":6163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":16305,"source":{"system":"sec-edgar","filing":"0001396814-25-000084","document":"wk-form4_1749845879.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000084/wk-form4_1749845879.xml","form_type":"4"}},{"id":1111149,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:17:55.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":11279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":11279,"derivative":{"exercise_price":24.34,"exercise_date":"2026-06-11","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":11279},"source":{"system":"sec-edgar","filing":"0001396814-25-000083","document":"wk-form4_1749845868.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000083/wk-form4_1749845868.xml","form_type":"4"}},{"id":1111148,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T20:17:55.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":6163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":13393,"source":{"system":"sec-edgar","filing":"0001396814-25-000083","document":"wk-form4_1749845868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000083/wk-form4_1749845868.xml","form_type":"4"}},{"id":1111147,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38597,"kind":"person","name":"CHRISTIE CHRISTOPHER","position":1,"cik":"0001787688","reported_name":"CHRISTIE CHRISTOPHER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:17:43.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":11279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":11279,"derivative":{"exercise_price":24.34,"exercise_date":"2026-06-11","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":11279},"source":{"system":"sec-edgar","filing":"0001396814-25-000082","document":"wk-form4_1749845857.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000082/wk-form4_1749845857.xml","form_type":"4"}},{"id":1111146,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38597,"kind":"person","name":"CHRISTIE CHRISTOPHER","position":1,"cik":"0001787688","reported_name":"CHRISTIE CHRISTOPHER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T20:17:43.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":6163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":16654,"source":{"system":"sec-edgar","filing":"0001396814-25-000082","document":"wk-form4_1749845857.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000082/wk-form4_1749845857.xml","form_type":"4"}},{"id":1111145,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38596,"kind":"person","name":"Young Alethia","position":1,"cik":"0001918147","reported_name":"Young Alethia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:17:33.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":11279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":11279,"derivative":{"exercise_price":24.34,"exercise_date":"2026-06-11","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":11279},"source":{"system":"sec-edgar","filing":"0001396814-25-000081","document":"wk-form4_1749845846.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000081/wk-form4_1749845846.xml","form_type":"4"}},{"id":1111144,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38596,"kind":"person","name":"Young Alethia","position":1,"cik":"0001918147","reported_name":"Young Alethia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T20:17:33.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":6163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":11393,"source":{"system":"sec-edgar","filing":"0001396814-25-000081","document":"wk-form4_1749845846.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000081/wk-form4_1749845846.xml","form_type":"4"}},{"id":1111184,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:17:22.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":11279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":11279,"derivative":{"exercise_price":24.34,"exercise_date":"2026-06-11","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":11279},"source":{"system":"sec-edgar","filing":"0001396814-25-000080","document":"wk-form4_1749845835.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000139681425000080/wk-form4_1749845835.xml","form_type":"4"}},{"id":1111183,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T20:17:22.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":6163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":23715,"source":{"system":"sec-edgar","filing":"0001396814-25-000080","document":"wk-form4_1749845835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000139681425000080/wk-form4_1749845835.xml","form_type":"4"}},{"id":1111740,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T16:18:16.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":11279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":11279,"derivative":{"exercise_price":24.34,"exercise_date":"2026-06-11","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":11279},"source":{"system":"sec-edgar","filing":"0001396814-25-000085","document":"wk-form4_1749845889.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000139681425000085/wk-form4_1749845889.xml","form_type":"4"}},{"id":1111739,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T16:18:16.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":6163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":20636,"source":{"system":"sec-edgar","filing":"0001396814-25-000085","document":"wk-form4_1749845889.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000139681425000085/wk-form4_1749845889.xml","form_type":"4"}},{"id":1120978,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-06-05T21:40:22.000Z","date":"2025-06-04","kind":"sale","planned":false,"acquired":false,"shares":5578.335,"price":26.21,"value":146208.16035,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.15 to $26.38, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2."}],"balance_after":59564,"source":{"system":"sec-edgar","filing":"0001396814-25-000069","document":"wk-form4_1749159397.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000069/wk-form4_1749159397.xml","form_type":"4"}},{"id":1120977,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-06-05T21:40:22.000Z","date":"2025-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":3374,"price":26.4,"value":89073.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."}],"balance_after":65142.335,"source":{"system":"sec-edgar","filing":"0001396814-25-000069","document":"wk-form4_1749159397.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000069/wk-form4_1749159397.xml","form_type":"4"}},{"id":1121125,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":40880,"kind":"person","name":"WILLIAMS KRISTEN","position":1,"cik":"0001296965","reported_name":"WILLIAMS KRISTEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Common Stock","published_at":"2025-06-05T21:37:51.000Z","date":"2025-06-04","kind":"sale","planned":false,"acquired":false,"shares":14376,"price":26.24,"value":377226.24,"ownership":{"direct":true},"balance_after":161574,"source":{"system":"sec-edgar","filing":"0001396814-25-000068","document":"wk-form4_1749159376.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1296965/000139681425000068/wk-form4_1749159376.xml","form_type":"4"}},{"id":1121124,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":40880,"kind":"person","name":"WILLIAMS KRISTEN","position":1,"cik":"0001296965","reported_name":"WILLIAMS KRISTEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Common Stock","published_at":"2025-06-05T21:37:51.000Z","date":"2025-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":6162,"price":26.4,"value":162676.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."}],"balance_after":175950,"source":{"system":"sec-edgar","filing":"0001396814-25-000068","document":"wk-form4_1749159376.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296965/000139681425000068/wk-form4_1749159376.xml","form_type":"4"}},{"id":1121524,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-06-05T21:37:39.000Z","date":"2025-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":5084,"price":26.4,"value":134217.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."}],"balance_after":181959.511,"source":{"system":"sec-edgar","filing":"0001396814-25-000067","document":"wk-form4_1749159413.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000139681425000067/wk-form4_1749159413.xml","form_type":"4"}},{"id":1285205,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-04T23:26:04.000Z","date":"2025-02-01","kind":"grant","planned":false,"acquired":true,"shares":93600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on February 1, 2026, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":187043.511,"source":{"system":"sec-edgar","filing":"0001396814-25-000033","document":"wk-form4_1738711558.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000139681425000033/wk-form4_1738711558.xml","form_type":"4"}},{"id":1284392,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":40880,"kind":"person","name":"WILLIAMS KRISTEN","position":1,"cik":"0001296965","reported_name":"WILLIAMS KRISTEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Common Stock","published_at":"2025-02-04T23:25:54.000Z","date":"2025-02-01","kind":"grant","planned":false,"acquired":true,"shares":79200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on February 1, 2026, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":182112,"source":{"system":"sec-edgar","filing":"0001396814-25-000032","document":"wk-form4_1738711548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296965/000139681425000032/wk-form4_1738711548.xml","form_type":"4"}},{"id":1284015,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":44453,"kind":"person","name":"Lee Frank D.","position":1,"cik":"0001814686","reported_name":"Lee Frank D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-04T23:25:44.000Z","date":"2025-02-01","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on February 1, 2026, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":448409,"source":{"system":"sec-edgar","filing":"0001396814-25-000031","document":"wk-form4_1738711538.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000031/wk-form4_1738711538.xml","form_type":"4"}},{"id":1284014,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T23:25:33.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":99500,"price":26.59,"value":2645705.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments\nover the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":99500,"derivative":{"exercise_price":26.59,"expiration_date":"2036-02-04","underlying":"Common Stock","underlying_shares":99500},"source":{"system":"sec-edgar","filing":"0001396814-25-000030","document":"wk-form4_1738711527.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000030/wk-form4_1738711527.xml","form_type":"4"}},{"id":1284013,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-02-04T23:25:33.000Z","date":"2025-02-01","kind":"grant","planned":false,"acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on February 1, 2026, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":54000,"source":{"system":"sec-edgar","filing":"0001396814-25-000030","document":"wk-form4_1738711527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000030/wk-form4_1738711527.xml","form_type":"4"}},{"id":1284012,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-02-04T23:25:23.000Z","date":"2025-02-01","kind":"grant","planned":false,"acquired":true,"shares":30600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on February 1, 2026, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":68516.335,"source":{"system":"sec-edgar","filing":"0001396814-25-000029","document":"wk-form4_1738711516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000029/wk-form4_1738711516.xml","form_type":"4"}},{"id":1309859,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":44453,"kind":"person","name":"Lee Frank D.","position":1,"cik":"0001814686","reported_name":"Lee Frank D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-06T23:23:19.000Z","date":"2025-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":9375,"price":18.33,"value":171843.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":98409,"source":{"system":"sec-edgar","filing":"0001396814-25-000008","document":"wk-form4_1736205793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000008/wk-form4_1736205793.xml","form_type":"4"}},{"id":1311046,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-01-06T23:23:10.000Z","date":"2025-01-06","kind":"sale","planned":true,"acquired":false,"shares":879,"price":18.4,"value":16173.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":93443.511,"source":{"system":"sec-edgar","filing":"0001396814-25-000007","document":"wk-form4_1736205784.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000139681425000007/wk-form4_1736205784.xml","form_type":"4"}},{"id":1311045,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-01-06T23:23:10.000Z","date":"2025-01-02","kind":"tax_withholding","planned":true,"acquired":false,"shares":371,"price":18.33,"value":6800.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 386.765 shares of common stock acquired under the issuer's employee stock purchase plan in December 2024."}],"balance_after":94322.511,"source":{"system":"sec-edgar","filing":"0001396814-25-000007","document":"wk-form4_1736205784.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000139681425000007/wk-form4_1736205784.xml","form_type":"4"}}],"next_cursor":"2025-01-06T23:23:10.000000Z,1311045"}